Search Results 281-290 of 18176 for Immunode

1. A Trial of the Effectiveness, Safety, and Tolerability of a Single Oral Administration of CP101 for the Prevention of Recurrent Clostridioides difficile Infection (PRISM4) - Mayo Clinic

   ... immunodeficiency, severe combined immunodeficiency, or human immunodeficiency virus/acquired immune deficiency syndrome. History of solid organ ...

2. VSV-hIFNbeta-NIS in Treating Patients With Stage IV or Recurrent Endometrial Cancer - Mayo Clinic

   HIV positive test result or other immunodeficiency or immunosuppression. History of hepatitis B or C or chronic hepatitis. Other concurrent chemotherapy ...

3. A Study Using a New Drug, Nivolumab, in Combination With Chemotherapy Drugs to Treat a Type of Cancer Called Nasopharyngeal Carcinoma (NPC) - Mayo Clinic

   * Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months and T-cell count ...

4. A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301) - Mayo Clinic

   Known diagnosis of human immunodeficiency virus (HIV) infection. Women who are pregnant or breast-feeding. Prior anaphylactic or other severe infusion ...

5. Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma - Mayo Clinic

   Known history of human immunodeficiency virus (HIV) (HIV 1/2 antibodies). Uncontrolled intercurrent illness including, but not limited to, ongoing or active ...

6. Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients with Newly Diagnosed Hodgkin Lymphoma - Mayo Clinic

   Patients with an immunodeficiency that existed prior to diagnosis, such as primary immunodeficiency syndromes, organ transplant recipients and children on ...

7. A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia - Mayo Clinic

   ... immunodeficiency virus (HIV) or hepatitis C virus (HCV). Subject who has history of primary immunodeficiency or tuberculosis. Subject who other invasive ...

8. Impact of Surgical Removal or Reduction Procedures on Markers of Immune Function in Adult Patients with Renal and Bladder Tumors and Pediatric Patients with Genitourinary Tumors - Mayo Clinic

   transplant, immunodeficiency syndromes, HIV/AIDS); Auto-immune disease (ex. lupus, rheumatoid arthritis, inflammatory bowel disease, etc.) Pregnancy. Subjects ...

9. RLY-2608-201-Ph2 Study Of RLY-2608 In PROS And PIK3CA Driven Malformations - Mayo Clinic

   Known human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV) infection unless meeting the following criteria: Participant ...

10. Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma - Mayo Clinic

    ... immunodeficiency virus (HIV) testing is not required for entry into this ... A known history of human immunodeficiency virus (HIV) (HIV 1/2 antibodies) ...